About Dark Biotechnology
Dark Biotechnology is an independent online publication covering the biotechnology industry for professional readers: companies, pipelines, regulation, genetics, and the devices built on both.
The name is the brand; the coverage is the business and science of applied biotech, reported from open sources. Every trial and financial figure carries its disclosure basis, and nothing here is investment or medical advice.
Who writes for Dark Biotechnology
Dr. Charlotte MeyerDr. Charlotte Meyer covers research for Dark Biotechnology: peer-reviewed findings with the method, the population and the gap named, keeping the distance between paper and clinic visible.
Dr. Nathan PryceDr. Nathan Pryce covers the biotech industry for Dark Biotechnology: companies, pipelines, financing and FDA decisions, with endpoint results and dollar figures carrying their disclosure basis.
Oliver StrnadOliver Strnad covers devices and medtech for Dark Biotechnology: clearances, approvals and specifications from makers' documentation, with limits stated as limits.
Ravi IyerRavi Iyer covers the business of biotech for Dark Biotechnology: funding rounds, hiring, partnerships and market moves, figures labeled company-claimed where the company is the only source.
Yuki TanakaYuki Tanaka covers genetics for Dark Biotechnology: engineering platforms and research translated honestly, with what was measured, in what model, and what it does not yet mean for patients.
Part of the VUGA Network
Dark Biotechnology is published by VUGA Enterprises LLC, Miami, Florida. The network is a group of independent digital magazines covering finance, technology, government, business, real estate, travel, health, fashion, entertainment, music, arts, sports, education, gaming, marketing and local news across the United States.
See all publications in the network · Meet the writers · Advertise with us